The reaffirmation of the Equal-Weight rating and price target by Morgan Stanley suggests a neutral outlook on SNV's stock in the short term. This indicates that the analyst believes the stock is fairly valued at its current price level, neither undervalued nor overvalued. Therefore, the impact on the stock price is likely to be minimal in the short term, as the market has likely already priced in the analyst's expectations.